A Case of Severe Sprue-Like Enteropathy Associated With Valsartan

Margot L. Herman; Alberto Rubio-Tapia; Tsung-Teh Wu; Joseph A. Murray

doi:10.14309/crj.2015.15

journal article Open Access Jan 01, 2015

A Case of Severe Sprue-Like Enteropathy Associated With Valsartan

Margot L. Herman Alberto Rubio-Tapia

Tsung-Teh Wu Joseph A. Murray

ACG Case Reports Journal Vol. 2 No. 1 pp. 92-94 · Ovid Technologies (Wolters Kluwer Health)

View at Publisher Save 10.14309/crj.2015.15

Topics

No keywords indexed for this article. Browse by subject →

References

11

[1]

James "2014 Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8)." JAMA (2014) 10.1001/jama.2013.284427

[2]

Rubio-Tapia "Severe spruelike enteropathy associated with olmesartan." Mayo Clin Proc (2012) 10.1016/j.mayocp.2012.06.003

[3]

Dreifuss "Spruelike enteropathy associated with olmesartan: An unusual case of severe diarrhea." Case Rep Gastrointest Med (2013)

[4]

DeGaetani "Villous atrophy and negative celiac serology: A diagnostic and therapeutic dilemma." Am J Gastroenterol (2013) 10.1038/ajg.2013.45

[5]

Abdelghany "Olmesartan associated sprue-like enteropathy and colon perforation." Case Rep Gastrointest Med (2014)

[6]

Nielsen "Angiotensin-II inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug." World J Gastroenterol (2013) 10.3748/wjg.v19.i40.6928

[7]

Marthey "Olmesartan-associated enteropathy: Results of a national survey." Aliment Pharmacol Ther (2014) 10.1111/apt.12937

[8]

Flesch "Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man." Eur J Clin Pharmacol (1997) 10.1007/s002280050259

[9]

Lebwohl "Editorial: Sprue-like enteropathy due to olmesartan and other angiotensin receptor blockers-the plot thickens." Aliment Pharmacol Ther (2014) 10.1111/apt.12960

[10]

Rubio-Tapia "Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease." J Clin Gastroenterol (2009) 10.1097/mcg.0b013e3181557e67

[11]

Rubio-Tapia "Sprue-like enteropathy associated with olmesartan: Broadening the differential diagnosis of enteropathy." Aliment Pharmacol Ther (2014) 10.1111/apt.13000

Cited By

52

Systematic review: Clinical phenotypes, histopathological features and prognosis of enteropathy due to angiotensin II receptor blockers

Annalisa Schiepatti, Paolo Minerba · 2024

Alimentary Pharmacology & Thera...

Olmesartan-associated enteropathy: Belgian survey

Abire Allaoui, Diane Marcoux · 2021

Therapies

Use of olmesartan and enteropathy outcomes: a multi‐database study

Y.‐H. Dong, Y. Jin · 2018

Alimentary Pharmacology & Thera...

A Case of Severe Sprue-like Enteropathy Associated With Losartan

Aurelio Negro, Giovanni Maria Rossi · 2015

Journal of Clinical Gastroenterolog...

Metrics

52

Citations

11

References

Details

Published: Jan 01, 2015
Vol/Issue: 2(1)
Pages: 92-94

Authors

Cite This Article

Margot L. Herman, Alberto Rubio-Tapia, Tsung-Teh Wu, et al. (2015). A Case of Severe Sprue-Like Enteropathy Associated With Valsartan. ACG Case Reports Journal, 2(1), 92-94. https://doi.org/10.14309/crj.2015.15

A Case of Severe Sprue-Like Enteropathy Associated With Valsartan

You May Also Like